Search Results - Zilko, P*
-
1
-
2
-
3
-
4
-
5
A Translational Medicine perspective of the development of torcetrapib: Does the failure of torcetrapib development cast a shadow on future development of lipid modifying agents, HDL elevation strategies or CETP as a viable molecular target for atherosclerosis? A case study of the use of biomarkers and Translational Medicine in atherosclerosis drug discovery and development
Published in Biochemical pharmacologyGet full text
Article -
6
-
7